Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation

European Journal of Cell Biology

Volumn 70, Issue 2, 1996, Pages 117-124

  He, Qimin ^a   Skog, Sven ^a   Wang, Naining ^a   Eriksson, Staffan ^b   Tribukait, Bernhard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Polyclonal antiserum against TK1; TK1; Tumor marker

Indexed keywords

CELL MARKER; CYTOPLASM PROTEIN; ENZYME ANTIBODY; SYNTHETIC PEPTIDE; THYMIDINE KINASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STRUCTURE ACTIVITY RELATION;

EID: 0029997983     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Anér, E. S., S. Eriksson: Mammalian deoxynucleoside kinase: Pharmac. Ther. 67, 155-186 (1995).
2. Bohman, C., S. Eriksson: Deoxycytidine kinase from human leukemic spleen: preparation and characterization of homogeneouse enzyme. Biochemistry 27, 4258-4265 (1988).
3. Bradshaw, H. D. Jr., P. L. Deininger: Human thymidine kinase gene: Molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells. Mol. Cell. Biol. 4, 2316-2320 (1984).
4. Brent, T.P.: Periodicity of DNA synthetic enzymes during the HeLa cell cycle. Cell Tissue Kinet. 4, 297-305 (1971).
5. Castro, J., Th. Heiden, N. Wang, B. Tribukait: Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry 14, 793-804 (1993).
6. Flemington, E. Jr., H. D. Bradshaw, V. Traina-Dorge, V. Slagel, P. L. Deininger: Sequence, structure and promoter characterization of the human thymidine kinase gene. Gene 52, 267-277 (1987).
7. Gronowitch, J. S., H. Hagberg, C. F. R. Källander, B. Simonsson: The use of serum deoxythymidine kinase as a prognostic marker in the monitoring of patients with non-Hodgkin's lymphoma. Br. J. Cancer 47, 487-495 (1983).
8. Jacobsson, B., S. Britton, Q. He, A. Karlsson, S. Eriksson: Decreased thymidine kinase levels in pheripheral blood cells from HIV seropositive individuals, implications for zidovudine metabolism. AIDS Res. & Human Retrovir. 11, 805-811 (1995).
9. Hall, P. A., A. L. Woods: Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet. 23, 505-522 (1990).
10. Hallek, M., L. Wanders, S. Strohmeyer, B. Emmerich: Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications. Ann. Hematol 65, 1-5 (1992).
11. He, Q., S. Skog, I. Welander, B. Tribukait: Enzyme kinetics of thymidine isoenzymes of Ehrlich ascites tumour. Anticancer Res. 10, 1257-1264 (1990).
12. He, Q., S. Skog, B. Tribukait: Cell cycle related studies on thymidine kinase and its isoenzymes in Ehrlich ascites tumours. Cell Prolif. 24, 3-14 (1991).
13. Jansson, O., C. Bohman, B. Munck-Petersen, S. Eriksson: Mammalian thymidine kinase 2: Direct photoaffinity labeling with 32P-dTTP of the enzyme from spleen, liver, heart and brain. Eur. J. Biochem. 206, 485-490 (1992).
14. Johnson, L. F., L. G. Rao, A. J. Muench: Regulation of thymidine kinase enzyme level in serum-stimulated mouse 3T6 fibroblasts. Exp. Cell Res. 138, 78-85 (1982).
15. Kauffman, M. G., T. J. Kelly: Cell cycle regulation of thymidine kinase: Residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis. Mol. Cell. Biol. 11, 2583-2546 (1991).
16. Lin, P. F., H. B. Lieberman, D. B. Yeh, T. Xu, S. Y. Zhao, F. H. Ruddle: Molecular cloning and structural analysis of murine thymidine kinase genomic and cDNA sequences. Mol. Cell. Biol. 5, 3149-3156 (1985).
17. Sauer, H., W. Wilmanns: Methods in Enzymatic Analysis. In: H. V. Bergmeyer, J. Bergmeyer, M. Geassl (eds.): Thymidine Kinase. Vol. III. pp. 468-473. Verlag Chemie. Weinheim 1983.
18. Sherley, J. L., T. J. Kelly: Regulation of human thymidine kinase during the cell cycle. J. Biol. Chem. 263, 8350-8358 (1988).
19. Sherley, J. L., T. J. Kelly: Human cytosolic thymidine kinase. Purification and physical characterization of the enzyme from HeLa cells. J. Biol. Chem. 263, 375-382 (1988).
20. Skog, S., B. Tribukait, G. Sundius: Energy metabolism and ATP turnover time during the cell cycle of Ehrlich ascites tumour cells. Exp. Cell Res. 141, 23-29 (1982).
21. Stuart, P., O. Ito, S. E. Conrad: Induction of cellular thymidine kinase occurs at the mRNA level. Mol. Cell. Biol. 5, 1490-1497 (1985).
22. Studier, W. F., A. H. Rosenberg, J. J. Dunn, J. W. Dubendorff: Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185, 60-89 (1990).
23. Tabor, S.: Current protocols in Molecular Biology, In: F. M. Ausubel, R. Brent, R. E. Kingstone, D. D. Moore, J. G. Seidman, J. A. Smith, K. Struhl (eds.): Expression using the T7 RNA polymerase/promoter system. pp. 16.2.1-16.2.11. Greene Publishing and Wiley-Interscience. New York 1990.
24. Törnevik, Y., B. Ullman, J. Balzarini, B. Wahren, S. Eriksson: Cytotoxicity of 3′-azido-3′-deoxythymidine correlates with 3′-azidothymidine-5-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3′-azido-thymidine 5′-triphosphate (AZTTP) levels in cultures CEM T-lymphoblastoid cells. Biochem. Pharmacol. 49, 829-837 (1995).
25. Yang, H. C., A. B. Pardee: Insulin-like growth factor I regulation of transcription and replication enzyme induction necessary for DNA synthesis. J. Cell. Physiol. 127, 410-416 (1986).